CASE STUDY
Poor patient adherence is a problem that has gone "unsolved" for decades. But combining smart pill bottle technology with individualized feedback can drive the adherence that proves the investigational product efficacy and underwrites approvals.
In this case study we;
|
Highlight correlation between poor patient adherence and drug efficacy. |
|
Explain how using AARDEX® Groups' Smart Pill Bottle, the MEMS® Cap, in a study of Gilead's Truvada, optimized patient adherence rates. |
|
Share how the study helped inform the FDA's recommended approach to tackling poor patient adherence in clinical trials. |